Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DSHEA Implementation Would Get Funding Push Under Harkin/Hatch Bill

This article was originally published in The Tan Sheet

Executive Summary

FDA funding of $20 mil. in FY 2004 would be authorized for implementation of the Dietary Supplement Health & Education Act under a bill introduced July 31 by Sen. Tom Harkin (D-Iowa)

You may also be interested in...



Dietary Supplement Safety Issues Maintain Momentum On Capitol Hill

The Anabolic Steroid Control Act of 2004 is likely to see a markup in the House Judiciary Committee the week of March 29

Dietary Supplement Safety Issues Maintain Momentum On Capitol Hill

The Anabolic Steroid Control Act of 2004 is likely to see a markup in the House Judiciary Committee the week of March 29

Dietary Supplement Safety Issues Maintain Momentum On Capitol Hill

The Anabolic Steroid Control Act of 2004 is likely to see a markup in the House Judiciary Committee the week of March 29

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095762

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel